Chronic inflammatory conditions

Although atherosclerosis and rheumatoid arthritis (RA) are distinct disease states, both disorders are chronic inflammatory conditions and may have common mechanisms of disease perpetuation. At sites of inflammation, such as the arterial intima undergoing atherogen-esis or the rheumatoid joint, oxygen radicals, in the presence of transition-metal ions, may initiate the peroxidation of low-density lipoprotein (LDL) to produce oxidatively modified LDL (ox-LDL). Ox-LDL has several pro-inflammatory properties and may contribute to the formation of arterial lesions (Steinberg et /., 1989). Increased levels of lipid peroxidation products have been detected in inflammatory synovial fluid (Rowley et /., 1984 Winyard et al., 1987a Merry et al., 1991 Selley et al., 1992 detailed below), but the potential pro-inflammatory role of ox-LDL in the rheumatoid joint has not been considered. We hypothesize that the oxidation of LDL within the inflamed rheumatoid joint plays a pro-inflammatory role just as ox-LDL has the identical capacity within the arterial intima in atherosclerosis. 

A decrease in erythrocyte production can be multifactorial. A deficiency in nutrients (such as iron, vitamin B12, and folic acid) is a common cause that often is easily treatable. In addition, patients with cancer and CKD are at risk for developing a hypoproductive anemia. Furthermore, patients with chronic immune-related diseases (such as rheumatoid arthritis and systemic lupus erythematosus) can develop anemia as a complication of their disease. Anemia related to these chronic inflammatory conditions is typically termed anemia of chronic disease. 

SECs, like the vascular endothehum, play an active part in the control of leucocyte recruitment in cases of acute and chronic inflammatory conditions. Eeucocyte recruitment from the blood compartment is a crucial determinant for the induction of immunity and inflammation. SECs control this process by producing cytokines that activate leucocytes and by expressing adhesion molecules. Under inflammatory conditions upregulation of intracellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) was found [35 36], as well as expression of E-selectin and P-selectin [37]. Together with the expression of CD4 on SECs it has been postulated that these adhesion molecules might also be involved in the adhesion of KC cells to the sinusoidal wall [20]. 

Naphazoline is used in severe rhinitis associated with colds, allergic reactions, and severe and chronic inflammatory conditions, in particular for inflammation of the antrum of Highmore as well as for stopping nosebleeds. Synonyms of naphazoline are nafazair, sanorin, rinazin, and privine. 

H4 blockers have potential in chronic inflammatory conditions such as asthma, in which eosinophils and mast cells play a prominent role. No selective H4 ligand is available for use in humans, but in addition to research agents listed in Table 16-1, many Hi-selective blockers (diphenhydramine, cetirizine, loratadine) show some affinity for this receptor. Several studies have suggested that H4-receptor antagonists may be useful in pruritus. 

Reduction of inflammation with nonsteroidal anti-inflammatory drugs (NSAIDs) often results in relief of pain for significant periods. Furthermore, most of the nonopioid analgesics (aspirin, etc) have anti-inflammatory effects, so they are appropriate for the treatment of both acute and chronic inflammatory conditions. 

Asthma is a chronic inflammatory condition characterized by bronchial hyper-responsiveness and reversible airway obstruction. Cytokine release from a variety of cell types such as eosinophils, lymphocytes and other inflammatory cells produces epithelial sloughing, plasma protein extravasation from the tracheobronchial microcirculation and airway remodeling. Bronchial mucosal inflammation is present in all patients. The primary goal of asthma management is to maintain control of the disease process by reducing symptoms and improving lung function. 

Helicobacter pylori infections lead to chronic inflammatory condition of mucous membrane in the stomach and duodenum, thus they may contribute to allergization (Matysiak-Budnik et al., 2003). 

The oxidative modification of LDL has been implicated in atherosclerosis. This disease may be regarded as a chronic inflammatory condition, and here we discuss how oxidatively modified LDL (oLDL) may play a role not only in atherosclerosis but also in other chronic inflammatory diseases such as RA. LDL (Mr = 2.5 x 106) is one of the major plasma carriers of lipids, as well as the antioxidants vitamin E and (3-carotene. Because of its high content of unsaturated fatty acids, LDL is uniquely sensitive to lipid peroxidation [ 117]. 

Possible applications are extensive and include the treatment of pain (e.g. in burns), inflammation, neurogenic inflammation, oedema (including cerebral oedema and angio-oedema), shock (especially septic shock, probably with B, as well as B2 antagonists), rhinitis and asthma, pancreatitis and defective ion transport, such as cholera, Crohn s disease and cystic fibrosis, and chronic inflammatory conditions such as rheumatoid and osteoarthritis. 

Ginseng may overstimulate chronic inflammatory conditions such as arthritis. 

Premature infant up to 400mg/dL. Children 30-100 mg/dL. Old age up to 60mg/dL. Froin s syndrome lumbar fluid values are much higher than cisternal fluid values. Similar values may occur in certain other chronic inflammatory conditions of the nervous system. ... 

The cytokine-induced increase in endofhelial lipase expression and secretion by endofhehal ceUs is in marked contrast to fhe effect of cytokines on hepatic hpase and Upoprotein hpase expression. Feingold et al. found that cytokines down-regu-late Upoprotein hpase [19] and hepatic lipase [20] expression. Both acute and chronic inflammatory conditions are associated with decreased HDL levels [21]. A decrease in HL levels in inflammatory states would be expected to increase HDL levels. These results support fhe possibihty fhat endothelial lipase has a significant role in regulating HDL levels, especiaUy in inflammatory states. 

Inflammatory bowel diseases (IBD) are chronic inflammatory conditions which affect the gastrointestinal tract. They are characterized by a localized or diffuse granulomatous inflammatory process, accompanied by systemic manifestations. As ulceration and regeneration of the intestinal epithelium occurs during the course of the disease, angiogenesis is undoubtedly an integral part of the IBD pathology [148]. 

Cortisol also has anti-inflammatory and immunosuppressive actions, which under physiological conditions help to limit response to injury and infection. When used pharmacologically, these effects are useful in treating chronic inflammatory conditions (see Chapter 5, use in asthma and Chapter 7, use in rheumatic diseases). 

This is a diverse group of drugs that do not inhibit COX neither do they have analgesic or direct anti-inflammatory activity. They appear to suppress the disease process in rheumatoid arthritis and other chronic inflammatory conditions and may cause remission... 

---